Pertzye Market Report 2026

Pertzye Market Overview

• The Pertzye market growth in the historic period has been driven by rising prevalence of cystic fibrosis-related epi, increased diagnosis of chronic pancreatitis • Market expansion is supported by expansion of personalized digestive care, rising adoption of advanced enzyme formulations • Growth Driver: Rising Prevalence Of Chronic Pancreatitis Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pertzye Market?

Pertzye is a medication containing pancrelipase, a combination of lipase, protease, and amylase enzymes. It is used to treat exocrine pancreatic insufficiency (EPI), a condition where the pancreas cannot produce enough enzymes for proper digestion. Pertzye is uniquely formulated with a bicarbonate-buffered enteric coating, which helps deliver the enzymes to the small intestine, where they can aid in digesting fats, proteins, and carbohydrates effectively. The main types of indications for pertzye are exocrine pancreatic insufficiency (EPI) due to cystic fibrosis, exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis, exocrine pancreatic insufficiency (EPI) due to pancreatitis surgery, and other indications. Exocrine pancreatic insufficiency (EPI) in cystic fibrosis is a condition where the pancreas fails to produce enough digestive enzymes, leading to nutrient malabsorption, commonly treated with pancreatic enzyme replacements like pertzye. It is available in various formulations, such as delayed-release capsules and strength variants, and it is distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Pertzye Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of personalized digestive care, rising adoption of advanced enzyme formulations, increasing focus on long-term epi management, growing demand for high-strength enzyme variants, continued innovation in drug delivery coatings. Major trends in the forecast period include increasing use of pancreatic enzyme replacement therapies, growing demand for buffered enteric coatings, expansion of chronic epi management programs, enhanced focus on digestive efficacy, improved patient adherence through formulation innovation.

What Are The Drivers Of The Pertzye Market?

The rising prevalence of chronic pancreatitis is expected to propel the growth of the pertzye market going forward. Chronic pancreatitis is a long-term inflammation of the pancreas causing irreversible damage, digestive issues, and potential complications like diabetes. The prevalence of chronic pancreatitis is attributed to factors such as excessive alcohol consumption, genetic predisposition, autoimmune disorders, and long-term obstruction of the pancreatic ducts caused by gallstones or tumors. Pertzye effectively manages chronic pancreatitis by supplying essential pancreatic enzymes to aid digestion and alleviate symptoms of malabsorption in patients with exocrine pancreatic insufficiency. For instance, in August 2023, according to a population based epidemiology study published in the World Journal of Gastroenterology, a China-based journal, the point prevalence of chronic pancreatitis reached 45.52 per 100,000 individuals in Sichuan Province, China. Therefore, the rising prevalence of chronic pancreatitis is driving the growth of the pertzye industry. The growing focus on personalized medicine is expected to propel the growth of the pertzye market going forward. Personalized medicine is a tailored approach to healthcare that uses an individual's genetic, environmental, and lifestyle factors to optimize treatment and improve outcomes. The growing focus on personalized medicine is attributed to advancements in genomics and biotechnology, which enable more precise treatments tailored to individual genetic profiles, improving patient outcomes and reducing adverse effects. Pertzye, an enzyme replacement therapy, contributes to personalized medicine by providing tailored treatment for individuals with cystic fibrosis who have pancreatic insufficiency, improving digestion and nutrient absorption based on their specific needs. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the growing focus on personalized medicine is driving the growth of the pertzye industry. The increasing digestive disorders are expected to propel the growth of the pertzye market going forward. Digestive disorders refer to a range of conditions that affect the normal functioning of the digestive system, including the stomach, intestines, and other related organs. The rise in digestive disorders is attributed to poor diet, stress, sedentary lifestyles, and environmental toxins, all contributing to conditions like irritable bowel syndrome (IBS), acid reflux, and inflammatory bowel diseases (IBD). Pertzye is a medication that assists with digestive disorders by providing pancreatic enzymes, which aid in the breakdown of fats, proteins, and carbohydrates, improving digestion in individuals with pancreatic insufficiency. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, reaching over 5,300 individuals with Inflammatory Bowel Disease (IBD) by 2023, this represents an increase of more than 3,000 members compared to 2022. Therefore, the increasing digestive disorders are driving the growth of the pertzye industry.

Key Players In The Global Pertzye Market

Major companies operating in the pertzye market are Digestive Care Inc.

What Defines the Pertzye Market?

The pertzye market consists of sales of pancrelipase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pertzye Market Report 2026?

The pertzye market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pertzye industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.